56 related articles for article (PubMed ID: 19394307)
1. Syndecan-2 overexpression regulates adhesion and migration through cooperation with integrin alpha2.
Choi S; Kim Y; Park H; Han IO; Chung E; Lee SY; Kim YB; Lee JW; Oh ES; Yi JY
Biochem Biophys Res Commun; 2009 Jun; 384(2):231-5. PubMed ID: 19394307
[TBL] [Abstract][Full Text] [Related]
2. HLA-B influences integrin beta-1 expression and pancreatic cancer cell migration.
Sliker BH; Goetz BT; Barnes R; King H; Maurer HC; Olive KP; Solheim JC
Exp Cell Res; 2020 May; 390(2):111960. PubMed ID: 32194036
[TBL] [Abstract][Full Text] [Related]
3. Syndecan-1-Dependent Regulation of Heparanase Affects Invasiveness, Stem Cell Properties, and Therapeutic Resistance of Caco2 Colon Cancer Cells.
Katakam SK; Pelucchi P; Cocola C; Reinbold R; Vlodavsky I; Greve B; Götte M
Front Oncol; 2020; 10():774. PubMed ID: 32477959
[TBL] [Abstract][Full Text] [Related]
4. Editorial overview: cell adhesion and migration.
Huttenlocher A; Sahai E
Curr Opin Cell Biol; 2014 Oct; 30():v-vi. PubMed ID: 25179864
[No Abstract] [Full Text] [Related]
5. Syndecan-2 is a key regulator of transforming growth factor beta 2/Smad2-mediated adhesion in fibrosarcoma cells.
Mytilinaiou M; Bano A; Nikitovic D; Berdiaki A; Voudouri K; Kalogeraki A; Karamanos NK; Tzanakakis GN
IUBMB Life; 2013 Feb; 65(2):134-43. PubMed ID: 23297089
[TBL] [Abstract][Full Text] [Related]
6. The extracellular domain of syndecan-2 regulates the interaction of HCT116 human colon carcinoma cells with fibronectin.
Kwon MJ; Kim Y; Choi Y; Kim SH; Park S; Han I; Kang DH; Oh ES
Biochem Biophys Res Commun; 2013 Feb; 431(3):415-20. PubMed ID: 23333331
[TBL] [Abstract][Full Text] [Related]
7. Analysis of
Park YS; Kim DS; Cho SW; Park JW; Jeon SJ; Moon TJ; Kim SH; Son BK; Oh TJ; An S; Kim JH; Chae JD
Gut Liver; 2018 Sep; 12(5):508-515. PubMed ID: 29730903
[TBL] [Abstract][Full Text] [Related]
8. Emerging roles of syndecan 2 in epithelial and mesenchymal cancer progression.
Mytilinaiou M; Nikitovic D; Berdiaki A; Kostouras A; Papoutsidakis A; Tsatsakis AM; Tzanakakis GN
IUBMB Life; 2017 Nov; 69(11):824-833. PubMed ID: 28940845
[TBL] [Abstract][Full Text] [Related]
9. Shed syndecan-2 enhances tumorigenic activities of colon cancer cells.
Choi S; Choi Y; Jun E; Kim IS; Kim SE; Jung SA; Oh ES
Oncotarget; 2015 Feb; 6(6):3874-86. PubMed ID: 25686828
[TBL] [Abstract][Full Text] [Related]
10. Syndecan-2 is upregulated in colorectal cancer cells through interactions with extracellular matrix produced by stromal fibroblasts.
Vicente CM; Ricci R; Nader HB; Toma L
BMC Cell Biol; 2013 May; 14():25. PubMed ID: 23705906
[TBL] [Abstract][Full Text] [Related]
11. Syndecan-2 functions as a docking receptor for pro-matrix metalloproteinase-7 in human colon cancer cells.
Ryu HY; Lee J; Yang S; Park H; Choi S; Jung KC; Lee ST; Seong JK; Han IO; Oh ES
J Biol Chem; 2009 Dec; 284(51):35692-701. PubMed ID: 19858218
[TBL] [Abstract][Full Text] [Related]
12. Integrated single-cell RNA sequencing analysis reveals a mesenchymal stem cell-associated signature for estimating prognosis and drug sensitivity in gastric cancer.
Shen K; Chen B; Gao W
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11829-11847. PubMed ID: 37410142
[TBL] [Abstract][Full Text] [Related]
13. Highlighting In Vitro the Role of Brain-like Endothelial Cells on the Maturation and Metabolism of Brain Pericytes by SWATH Proteomics.
Menaceur C; Hachani J; Dib S; Duban-Deweer S; Karamanos Y; Shimizu F; Kanda T; Gosselet F; Fenart L; Saint-Pol J
Cells; 2023 Mar; 12(7):. PubMed ID: 37048083
[TBL] [Abstract][Full Text] [Related]
14. Methylation of CpG island promoters at
Iwaizumi M; Taniguchi T; Kurachi K; Osawa S; Sugimoto K; Baba S; Sugimura H; Maekawa M
Oncol Lett; 2023 Jan; 25(1):14. PubMed ID: 36478906
[TBL] [Abstract][Full Text] [Related]
15. Substituted Syndecan-2-Derived Mimetic Peptides Show Improved Antitumor Activity over the Parent Syndecan-2-Derived Peptide.
Jang B; Kim A; Lee Y; Hwang J; Sung JY; Jang EJ; Kim YN; Yun JH; Han J; Song JJ; Lee W; Oh ES
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682569
[TBL] [Abstract][Full Text] [Related]
16. The Cardiac Syndecan-2 Interactome.
Mathiesen SB; Lunde M; Stensland M; Martinsen M; Nyman TA; Christensen G; Carlson CR
Front Cell Dev Biol; 2020; 8():792. PubMed ID: 32984315
[TBL] [Abstract][Full Text] [Related]
17. Heparan Sulfate Proteoglycan Signaling in Tumor Microenvironment.
De Pasquale V; Pavone LM
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32916872
[TBL] [Abstract][Full Text] [Related]
18. Emerging Role of Syndecans in Extracellular Matrix Remodeling in Cancer.
Jang B; Kim A; Hwang J; Song HK; Kim Y; Oh ES
J Histochem Cytochem; 2020 Dec; 68(12):863-870. PubMed ID: 32623937
[TBL] [Abstract][Full Text] [Related]
19. N-terminal syndecan-2 domain selectively enhances 6-O heparan sulfate chains sulfation and promotes VEGFA
Corti F; Wang Y; Rhodes JM; Atri D; Archer-Hartmann S; Zhang J; Zhuang ZW; Chen D; Wang T; Wang Z; Azadi P; Simons M
Nat Commun; 2019 Apr; 10(1):1562. PubMed ID: 30952866
[TBL] [Abstract][Full Text] [Related]
20. Heparan Sulfate Proteoglycans in Human Colorectal Cancer.
Vicente CM; da Silva DA; Sartorio PV; Silva TD; Saad SS; Nader HB; Forones NM; Toma L
Anal Cell Pathol (Amst); 2018; 2018():8389595. PubMed ID: 30027065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
